FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 18037523)

Published in Radiother Oncol on November 26, 2007

Authors

Tao Liu1, Wen Xu, Wei-Li Yan, Ming Ye, Yong-Rui Bai, Gang Huang

Author Affiliations

1: Department of Nuclear Medicine, Renji Hospital, Medical School of Shanghai Jiaotong University, Shanghai, PR China.

Articles citing this

Usefulness of CT angiography in diagnosing acute gastrointestinal bleeding: a meta-analysis. World J Gastroenterol (2010) 1.23

Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge. Curr Oncol (2013) 1.06

Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital (2013) 0.99

Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI. Br J Radiol (2014) 0.94

Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT. Eur Radiol (2010) 0.93

Early detection of nasopharyngeal carcinoma. Int J Otolaryngol (2011) 0.92

A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma. Radiat Oncol (2015) 0.87

Detecting plasma Epstein-Barr virus DNA to diagnose postradiation nasopharyngeal skull base lesions in nasopharyngeal carcinoma patients: a prospective study. Chin J Cancer (2012) 0.86

64-row MDCT perfusion of head and neck squamous cell carcinoma: technical feasibility and quantitative analysis of perfusion parameters. Eur Radiol (2010) 0.85

Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence. PLoS One (2015) 0.84

FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT. Eur Radiol (2015) 0.82

Value of (18)F-FDG heterogeneity for discerning metastatic from benign lymph nodes in nasopharyngeal carcinoma patients with suspected recurrence. Br J Radiol (2016) 0.75

The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: Preliminary findings. Br J Radiol (2017) 0.75

Articles by these authors

(truncated to the top 100)

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol (2011) 18.34

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet (2008) 6.93

Orai1 and STIM reconstitute store-operated calcium channel function. J Biol Chem (2006) 4.98

p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell (2009) 4.30

STIM1 has a plasma membrane role in the activation of store-operated Ca(2+) channels. Proc Natl Acad Sci U S A (2006) 3.32

STIM2 is an inhibitor of STIM1-mediated store-operated Ca2+ Entry. Curr Biol (2006) 2.38

A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc Natl Acad Sci U S A (2006) 2.30

Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology (2012) 2.15

Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry (2007) 2.11

Nucleation and growth of nanoparticles in the atmosphere. Chem Rev (2011) 1.99

A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun (2004) 1.99

Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care (2004) 1.97

Potential autoregulation of transcription factor PU.1 by an upstream regulatory element. Mol Cell Biol (2005) 1.96

PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element. Genes Dev (2008) 1.90

Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: a diagnostic meta-analysis. BMC Gastroenterol (2014) 1.82

Role of endogenous TRPC6 channels in Ca2+ signal generation in A7r5 smooth muscle cells. J Biol Chem (2005) 1.69

The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model. Int Immunol (2004) 1.63

Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China. Clin Ther (2011) 1.60

H1 family histones in the nucleus. Control of binding and localization by the C-terminal domain. J Biol Chem (2005) 1.59

Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev (2008) 1.51

CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol (2008) 1.50

The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science (2011) 1.49

Study of stone composition changes in melamine-related urinary calculi and its clinical significance. Urology (2011) 1.44

Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol (2011) 1.43

Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J (2012) 1.41

Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma. BMC Cancer (2013) 1.40

GDF6, a novel locus for a spectrum of ocular developmental anomalies. Am J Hum Genet (2006) 1.35

Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol (2010) 1.34

Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy. IUBMB Life (2013) 1.31

Involvement of GIGANTEA gene in the regulation of the cold stress response in Arabidopsis. Plant Cell Rep (2005) 1.29

Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol (2009) 1.26

Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms. EMBO Rep (2002) 1.25

Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis. Breast Cancer Res Treat (2011) 1.24

MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J Gastroenterol Hepatol (2009) 1.24

Anterior versus posterior surgery for multilevel cervical myelopathy, which one is better? A systematic review. Eur Spine J (2010) 1.23

The Pu.1 locus is differentially regulated at the level of chromatin structure and noncoding transcription by alternate mechanisms at distinct developmental stages of hematopoiesis. Mol Cell Biol (2007) 1.23

Decreased hephaestin activity in the intestine of copper-deficient mice causes systemic iron deficiency. J Nutr (2006) 1.23

The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4. Mol Pharmacol (2004) 1.22

Poly[[bis-[μ(2)-8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ato]zinc(II)] dihydrate]. Acta Crystallogr Sect E Struct Rep Online (2009) 1.21

Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. J Clin Invest (2013) 1.20

Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol (2010) 1.20

MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. Mol Pharm (2010) 1.20

Role of glycosylation in the organic anion transporter OAT1. J Biol Chem (2004) 1.19

Special fasciculiform cataract caused by a mutation in the gammaD-crystallin gene. Mol Vis (2004) 1.17

Independent category and spatial encoding in parietal cortex. Neuron (2013) 1.17

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin. Vaccine (2010) 1.17

Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery. ACS Nano (2011) 1.17

3-(1-Ethyl-1H-pyrrole-2-carboxamido)propionic acid monohydrate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.16

Inflammation in ischaemic brain injury: current advances and future perspectives. Clin Exp Pharmacol Physiol (2009) 1.16

Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry (2009) 1.15

Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypes. Hum Mol Genet (2009) 1.14

A simple and sensitive HPLC method for the simultaneous determination of eight bioactive components and fingerprint analysis of Schisandra sphenanthera. Anal Chim Acta (2010) 1.13

The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior. Cell Cycle (2009) 1.13

Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias. Blood (2012) 1.13

Multicolored pH-tunable and activatable fluorescence nanoplatform responsive to physiologic pH stimuli. J Am Chem Soc (2012) 1.13

Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase. Bioorg Med Chem Lett (2006) 1.12

Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn. Protein Sci (2009) 1.12

Interleukin-10-819 promoter polymorphism in association with gastric cancer risk. BMC Cancer (2012) 1.11

PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment. Cell Rep (2013) 1.09

A novel mechanistic spectrum underlies glaucoma-associated chromosome 6p25 copy number variation. Hum Mol Genet (2008) 1.09

Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives. Semin Oncol (2012) 1.09

Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res (2002) 1.09

Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells. Mol Cell (2013) 1.09

Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer. Clin Chem (2009) 1.08

Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (2006) 1.08

Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol (2010) 1.08

Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells. Mol Cancer Res (2012) 1.07

N-ethylpyridinium bis(2-thioxo-1,3-dithiole-4,5-dithiolato)nickelate. Acta Crystallogr C (2002) 1.07

X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis. Am J Epidemiol (2011) 1.06

Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus. Sci Signal (2012) 1.06

MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. Gastroenterology (2013) 1.05

Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreat Dis Int (2010) 1.05

Ultra-pH-sensitive nanoprobe library with broad pH tunability and fluorescence emissions. J Am Chem Soc (2014) 1.04

Case-control association study of Disrupted-in-Schizophrenia-1 (DISC1) gene and schizophrenia in the Chinese population. J Psychiatr Res (2006) 1.03

Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis. J Clin Lab Anal (2007) 1.03

Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication. J Virol (2002) 1.03

RuleBender: integrated modeling, simulation and visualization for rule-based intracellular biochemistry. BMC Bioinformatics (2012) 1.03

Decreased hephaestin expression and activity leads to decreased iron efflux from differentiated Caco2 cells. J Cell Biochem (2009) 1.02

Shape-specific polymeric nanomedicine: emerging opportunities and challenges. Exp Biol Med (Maywood) (2011) 1.01

Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells. Apoptosis (2007) 1.01

Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma. PLoS One (2013) 1.01

Waist circumference reference values for screening cardiovascular risk factors in Chinese children and adolescents. Biomed Environ Sci (2010) 1.00

[In vitro screening of 32 traditional Chinese herbal extracts against U2OS human osteosarcoma cells]. Nan Fang Yi Ke Da Xue Xue Bao (2006) 1.00

Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells. Cancer Biol Ther (2007) 0.99

The safety of olanzapine in adolescents with schizophrenia or bipolar I disorder: a pooled analysis of 4 clinical trials. J Clin Psychiatry (2009) 0.99

A prospective randomized controlled trial to compare Pringle maneuver, hemihepatic vascular inflow occlusion, and main portal vein inflow occlusion in partial hepatectomy. Am J Surg (2010) 0.99

Comparison of virtual cystoscopy and ultrasonography for bladder cancer detection: a meta-analysis. Eur J Radiol (2010) 0.99

CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells. Development (2010) 0.99

Effect of constituents from Fructus Aurantii Immaturus and Radix Paeoniae Alba on gastrointestinal movement. Planta Med (2008) 0.99

Protein kinase C δ increases Kruppel-like factor 4 protein, which drives involucrin gene transcription in differentiating keratinocytes. J Biol Chem (2013) 0.98

Adverse prognosis of clustered-cell versus single-cell micrometastases in pN0 early gastric cancer. J Surg Oncol (2011) 0.98

CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer. Lung Cancer (2011) 0.98

17-Beta-estradiol enhanced allodynia of inflammatory temporomandibular joint through upregulation of hippocampal TRPV1 in ovariectomized rats. J Neurosci (2010) 0.97

Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis. Eur J Radiol (2009) 0.97

MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML. Br J Haematol (2011) 0.97

Calcium entry mediated by SOCs and TRP channels: variations and enigma. Biochim Biophys Acta (2004) 0.96

MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes. Cell Signal (2013) 0.96

A meta-analysis of interleukin-8 -251 promoter polymorphism associated with gastric cancer risk. PLoS One (2012) 0.96

Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines. Acta Pharmacol Sin (2007) 0.96

Investigation of In Vivo Targeting Kinetics of α(v)β(3)-Specific Superparamagnetic Nanoprobes by Time-Resolved MRI. Theranostics (2011) 0.96